Insights

Market Position Company operates in the alternative medicine space with a small to mid-sized team (11-50 employees) and reported annual revenue in the range of 1M to 10M, indicating a growing niche business that may be open to efficiency and growth-focused partnerships or platforms.

Growth Opportunities Despite limited size, the revenue band suggests potential readiness for technology upgrades, digital marketing optimization, or scalable sales enablement tools to accelerate customer acquisition and expand market reach.

Tech Leveraging The provided data shows a focus on general tech history rather than current stack; sales teams could position modern CRM, analytics, or automation solutions to streamline patient outreach, appointment scheduling, and compliance in the alternative medicine sector.

Competitive Insight Presence of numerous news items referencing major email platforms implies a high emphasis on digital communications; there may be an opportunity to offer secure, compliant messaging, email deliverability, or customer engagement tools tailored for regulated/niche healthcare practices.

Strategic Fit Small to mid-sized organization with potential for partnerships in training, compliance consulting, or telehealth enablement; target for bundled solutions combining marketing automation, patient relationship management, and analytics to drive repeat visits and retention.

Similar companies to Blyk2

Blyk2's Email Address Formats

Blyk2 uses at least 1 email format:
Blyk2 Email FormatsExamplePercentage
FLast@kineconcept.comJDoe@kineconcept.com
100%

Frequently Asked Questions

How much revenue does Blyk2 generate?

Minus sign iconPlus sign icon
As of October 2026, Blyk2's annual revenue is estimated to be $1M - $10M.

What is Blyk2's SIC code and NAICS code?

Minus sign iconPlus sign icon
Blyk2's SIC code is 8049 - Offices and Clinics of Health Practitioners, Not Elsewhere Classified and NAICS code is 621399 - Offices of All Other Miscellaneous Health Practitioners.

How many employees does Blyk2 have currently?

Minus sign iconPlus sign icon
As of October 2026, Blyk2 has approximately 16 employees across 4 continents, including North America, Europe and Africa. Key team members include Co-Owner: R. G., Director: A. R. and Directeur: D. D. Explore Blyk2's employee directory with LeadIQ.

What industry does Blyk2 belong to?

Minus sign iconPlus sign icon
Blyk2 operates in the Alternative Medicine industry.

What is Blyk2's email format?

Minus sign iconPlus sign icon
Blyk2's email format typically follows the pattern of FLast@kineconcept.com. Find more Blyk2 email formats with LeadIQ.
Blyk2 logo

Blyk2

Alternative MedicineUnited States11-50 Employees

Blyk2 is an organization operating within the United States in the Alternative Medicine sector. Its size is described as moderate, and it is positioned to serve clients seeking alternative medicine approaches, though specific products or services are not detailed in the provided information. The company is based in the United States and falls within a field that includes other diverse healthcare and wellness offerings. While the available material does not specify founding dates, it situates Blyk2 within a market that intersects health-oriented services and nonconventional treatments. A recent development mentioned in external items references Hotmail-related content, but there is no explicit linkage to Blyk2 beyond the provided context; the only concrete recent development relevant to the company information is the general nature of the industry and location.

Section iconCompany Overview

SIC Code
8049 - Offices and Clinics of Health Practitioners, Not Elsewhere Classified
NAICS Code
621399 - Offices of All Other Miscellaneous Health Practitioners
Employees
11-50

Section iconFunding & Financials

  • $1M - $10M

    Blyk2's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.